Skip to main content

Women’s Health and Menopause

Risk Reduction Strategies

  • Book
  • © 1997

Overview

Part of the book series: Medical Science Symposia Series (MSSS, volume 11)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (47 chapters)

  1. Menopause as a Medical and Social Issue

  2. Ovarian Senescence

  3. Connective Tissue and Bone

  4. Osteoporosis

  5. Cardiovascular Risk

Keywords

About this book

Despite its universality in human female aging, the menopause and its biology are not completely understood. New biologic mechanisms by which sex hormones may be detrimental or confer protection are continually being discovered.
We are now starting to understand that the role of the estrogen receptor is not identical in all tissues. Important nongenomic effects for sex hormones have also been described. Hormone replacement therapy (HRT) has produced effects on health risks: some are reduced, some are increased, and the rest remain uncertain. HRT is being used by an increasing number of women to alleviate climacteric symptoms in the perimenopausal period and to prevent osteoporosis and cardiovascular disease later. Positive effects on Alzheimer's disease and dementia on the one hand, and an increase in venous thrombosis on the other, are currently being reported by several groups. Both the preventive benefits and the risk of breast cancer seem to be linked to long-term and current use. HRT requires further testing through specific clinical trials, currently underway in the United States, before confident recommendations may be made about the full range of benefits and risks.

Editors and Affiliations

  • Institute of Pharmacological Sciences, University of Milan, Milan, Italy

    R. Paoletti, M. R. Soma

  • Department of Obstetrics and Gynecology, University of Milan, Milan, Italy

    P. G. Crosignani

  • Department of Obstetrics and Gynaecology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands

    P. Kenemans

  • Department of Obstetrics and Gynecology, Lund University Hospital, Lund, Sweden

    G. Samsioe

  • Giovanni Lorenzini Medical Foundation, Houston, USA

    A. S. Jackson

Bibliographic Information

  • Book Title: Women’s Health and Menopause

  • Book Subtitle: Risk Reduction Strategies

  • Editors: R. Paoletti, P. G. Crosignani, P. Kenemans, G. Samsioe, M. R. Soma, A. S. Jackson

  • Series Title: Medical Science Symposia Series

  • DOI: https://doi.org/10.1007/978-94-011-5560-1

  • Publisher: Springer Dordrecht

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media Dordrecht 1997

  • Hardcover ISBN: 978-0-7923-4697-5Published: 31 August 1997

  • Softcover ISBN: 978-94-010-6343-2Published: 28 October 2012

  • eBook ISBN: 978-94-011-5560-1Published: 06 December 2012

  • Series ISSN: 0928-9550

  • Edition Number: 1

  • Number of Pages: XXIX, 341

  • Topics: Gynecology, Biochemistry, general, Epidemiology, Public Health

  • Industry Sectors: Biotechnology, Health & Hospitals, Pharma

Publish with us